Cogent Biosciences Inc share price logo

Cogent Biosciences Inc Share Price

NASDAQ: COGT

Small Cap

$12.62

+0.21

(+1.73%)

Live

as on

Cogent Biosciences Inc Stock Performance

as on September 16, 2025 at 11:41 pm IST

  • Day's Low

    Day's High

    $12.49
    $12.76
    downward going graph

    1.03%

    Downside

    1.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.72
    $13.5
    downward going graph

    70.52%

    Downside

    6.97%

    Upside

    downward going graph

Cogent Biosciences Inc share price movements today

Previous Close
$12.41
Open
$12.57
Volume
773.3K
Day's Low - High
$12.49 - $12.76
52 Week Low - High
$3.72 - $13.5

Cogent Biosciences Inc Historical Returns

1 Month Return
+ 4.37 %
3 Month Return
+ 65.69 %
1 Year Return
+ 14.7 %
3 Year Return
-21.36 %
5 Year Return
+ 338.52 %

Cogent Biosciences Inc Stock Fundamentals & Key Indicators

Check Cogent Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-2.1777

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-297.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

42215100.00%

Cogent Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cogent Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.8B338.52%NA0.00%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Cogent Biosciences Inc Stock including INR - Dollar returns

The Cogent Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Cogent Biosciences Inc investment value today

Current value as on today

₹1,21,503

Returns

₹21,503

(+21.5%)

Returns from Cogent Biosciences Inc Stock

₹16,636 (+16.64%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Cogent Biosciences Inc Stock

Based on 17 analysts

BUY

82.35%

Buy

17.65%

Hold

0.00%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Cogent Biosciences Inc. Average target price of $21.09

Cogent Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Cogent Biosciences Inc.

What analysts predicted

40.16%UPSIDE

Target Price

$21.09

Current Price

$12.62

Analyzed by

17 Analysts

Target

$21.09

Cogent Biosciences Inc target price $21.09, a slight upside of 40.16% compared to current price of $12.62. According to 17 analysts rating.

Cogent Biosciences Inc Stock's Interest Amongst Investors

Search interest for Cogent Biosciences Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Cogent Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
5
-
-
-
4
-
-
Gross Profit
0
-1
0
4
-1
-1
-1
2
-1
-1
Operating Income
-43
-47
-59
-58
-62
-64
-75
-73
-74
-75
EBITDA
-42
-46
-58
-57
-61
-63
-74
-66
-73
-72
Interest Expense
4
-
-
4
-
-
-
-
-
0
Depreciation
0
1
0
0
1
1
1
1
1
1
Income Before Tax
-38
-44
-55
-54
-58
-58
-70
-67
-71
-73
Income Tax Expense
-4
-3
0
-3
-4
-
-
-
-
-
Net Income
-33
-44
-55
-54
-58
-58
-70
-67
-71
-73
Net Profit Margin
0.00%
0.00%
0.00%
-972.89%
0.00%
0.00%
0.00%
-1582.64%
0.00%
0.00%

Cogent Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
6
8
9
22
7
-
-
-
-
Gross Profit
2
6
8
9
22
7
0
-5
-3
-4
Operating Income
-6
-19
-26
-36
-32
-82
-75
-147
-208
-275
EBITDA
-6
-18
-24
-34
-30
-34
-75
-141
-205
-275
Interest Expense
-
-
-
-
-
0
3
3
-
-
Depreciation
-
-
1
1
1
0
0
5
3
4
Income Before Tax
-6
-18
-25
-34
-31
-74
-72
-140
-192
-255
Income Tax Expense
-
0
0
1
-1
-8
0
-7
-
-
Net Income
-6
-18
-25
-34
-30
-66
-71
-132
-192
-255
Net Profit Margin
-220.76%
-285.19%
-304.93%
-354.76%
-134.55%
-844.25%
0.00%
0.00%
0.00%
0.00%

Cogent Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-44
-55
-54
-58
-58
-70
-67
-71
-73
Operating Cash Flow
-32
-37
-44
-52
-42
-51
-60
-66
-54
Investing Cash Flow
-77
-90
10
1
-84
60
61
69
8
Financing Cash Flow
162
1
-
214
0
0
0
24
47
Change in Cash
52
-127
-33
162
-127
8
1
27
1

Cogent Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-18
-25
-34
-31
-74
-72
-140
-192
-255
Operating Cash Flow
-18
-25
-32
-41
-35
-58
-118
-153
-207
Investing Cash Flow
-30
13
-10
23
8
-1
-124
-97
38
Financing Cash Flow
0
0
70
0
232
37
163
163
214
Change in Cash
-49
-13
27
-18
204
-22
-79
-87
44

Global Institutional Holdings in Cogent Biosciences Inc

Funds
Holdings
FMR Inc
12.24%
Kynam Capital Management, LP
6.53%
Paradigm Biocapital Advisors LP
6.43%
COMMODORE CAPITAL LP
6.38%
BlackRock Inc
5.86%

Insights on Cogent Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, COGT stock has moved up by 65.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 55.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 137.9%

About Cogent Biosciences Inc

unum therapeutics is a cambridge, massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. unum has built an antibody-coupled t-cell receptor (actr) platform that, when combined with tumor-specific antibodies, directs an individual’s cytotoxic t-lymphocytes (ctls) to kill tumor cells. in contrast to other approaches that hit a single target and treat a narrow set of tumors, unum’s approach is not restricted by antigens and may have applications for treating many types of cancers. unum’s vision: a single cell therapy that can augment the activity of multiple antibodies to treat many different cancers. unum's lead program based on actr technology is currently in phase i clinical testing to assess safety and efficacy in certain forms of leukemia and lymphoma. in parallel, unum is act
OrganisationCogent Biosciences Inc
Headquarters275 Wyman Street, Waltham, MA, United States, 02451
IndustryHealth Technology
CEOMr. Andrew R. Robbins M.B.A.
E-voting on sharesClick here to vote

Key Management of Cogent Biosciences Inc

Name

Title

Mr. Andrew R. Robbins M.B.A.

President, CEO & Director

Dr. John Edward Robinson Ph.D.

Chief Scientific Officer

Dr. Jessica Sachs M.D.

Chief Medical Officer

Mr. Cole Pinnow

Chief Commercial Officer

Mr. Brad Barnett

Chief Technology Officer

Ms. Christi Waarich

Senior Director of Investor Relations

Mr. John L. Green C.A., CPA

CFO & Principal Accounting Officer

Mr. Evan D. Kearns J.D.

Chief Legal Officer & Corporate Secretary

Ms. Erin Schellhammer

Chief People Officer

Mr. Dana R. Martin Pharm.D.

Senior VP of Medical Affairs & Chief Patient Officer

FAQs

What is Cogent Biosciences Inc share price today?

Cogent Biosciences Inc share price today is $12.62 as on . Cogent Biosciences Inc share today touched a day high of $12.76 and a low of $12.49.

What is the 52 week high and 52 week low for Cogent Biosciences Inc share?

Cogent Biosciences Inc share touched a 52 week high of $13.5 on and a 52 week low of $3.72 on . Cogent Biosciences Inc stock price today i.e. is trending at $12.62,which is 6.52% down from its 52 week high and 239.25% up from its 52 week low.

What is Cogent Biosciences Inc's market capitalisation today?

Cogent Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Cogent Biosciences Inc Stock (COGT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cogent Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cogent Biosciences Inc Shares that will get you 0.1189 shares as per Cogent Biosciences Inc share price of $12.62 per share as on September 16, 2025 at 11:41 pm IST.

What is the minimum amount required to buy Cogent Biosciences Inc Stock (COGT) from India?

Indian investors can start investing in Cogent Biosciences Inc (COGT) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Cogent Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cogent Biosciences Inc share’s latest price of $12.62 as on September 16, 2025 at 11:41 pm IST, you will get 0.7924 shares of Cogent Biosciences Inc. Learn more about fractional shares .

What are the returns that Cogent Biosciences Inc has given to Indian investors in the last 5 years?

Cogent Biosciences Inc stock has given 338.52% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?